Cargando…
Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated in symptoms after secukinumab: case report
BACKGROUND: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease that involves damage to the peripheral nervous system. The course of the disease can progress for more than 8 weeks, with frequent incidences of relapse-remission courses. This article reported a rare combi...
Autores principales: | Jin, Yan, Chu, Hong, Dong, Hongjuan, Wang, Hongyang, Wang, Qingping, Zhao, Xiaoquan, Qin, Dongdong, Lu, Zuneng, Weng, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628172/ https://www.ncbi.nlm.nih.gov/pubmed/36324078 http://dx.doi.org/10.1186/s12883-022-02928-3 |
Ejemplares similares
-
Ring finger sensory latency difference in the diagnosis and treatment of carpal tunnel syndrome
por: Wang, Qingping, et al.
Publicado: (2021) -
Multisequence Quantitative Magnetic Resonance Neurography of Brachial and Lumbosacral Plexus in Chronic Inflammatory Demyelinating Polyneuropathy
por: Su, Xiaoyun, et al.
Publicado: (2021) -
Use of Magnetic Resonance Neurography for Evaluating the Distribution and Patterns of Chronic Inflammatory Demyelinating Polyneuropathy
por: Su, Xiaoyun, et al.
Publicado: (2020) -
Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis
por: Zhang, Si, et al.
Publicado: (2022) -
Secukinumab in Generalized Pustular Psoriasis
por: Madanagobalane, Shraddha
Publicado: (2018)